Table 1 The clinical, pathologic, treatment characteristics in patients with stage III STS and their correlations with radiographic response
Issues | Catogaries | N | Radiographic response | χ | P | ||
|---|---|---|---|---|---|---|---|
PR | SD | PD | |||||
Age | Median | 42 years | |||||
Gender | Male | 67 | 15 | 39 | 13 | −0.02 | 0.831 |
Female | 53 | 10 | 36 | 7 | |||
Size(CM) | Mean | 10 cm | |||||
≥10 | 5 | 39 | 19 | 0.453 | <0.001 | ||
<10 | 20 | 36 | 1 | ||||
FNCLCC grade | 2 | 45 | 10 | 31 | 4 | 3.150 | 0.207 |
3 | 75 | 15 | 44 | 16 | |||
Subtype | MFH | 33 | 6 | 17 | 10 | 11.270 | 0.187 |
SS | 28 | 5 | 20 | 3 | |||
LS | 28 | 8 | 16 | 4 | |||
LMS | 16 | 1 | 13 | 2 | |||
Others | 15 | 5 | 9 | 1 | |||
Neo-AC cycles | 1 | 18 | 7 | 10 | 3 | 0.832 | 0.374 |
2 | 102 | 18 | 65 | 17 | |||
Chemotherapy regimen | MAID | 80 | 18 | 50 | 12 | 0.720 | 0.698 |
AIM | 40 | 7 | 25 | 8 | |||
UICC margin | R0 + R1 | 92 | 24 | 57 | 11 | 10.491 | 0.005 |
R2 | 28 | 1 | 18 | 9 | |||
Follow-up(M) | Median | 46.0 (13–158) | |||||